Vanguard Group Inc Dr Reddys Laboratories LTD Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Vanguard Group Inc holds 4,975,047 shares of RDY stock, worth $69.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,975,047
Previous 5,002,642 0.55%
Holding current value
$69.2 Million
Previous $66 Million 13.32%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$12.36 - $16.17 $341,074 - $446,211
-27,595 Reduced 0.55%
4,975,047 $74.8 Million
Q1 2025

May 09, 2025
BUY
$12.53 - $15.81 $1.33 Million - $1.68 Million
106,457 Added 2.17%
5,002,642 $66 Million
Q4 2024

Feb 11, 2025
BUY
$13.99 - $79.75 $54.7 Million - $312 Million
3,911,404 Added 397.19%
4,896,185 $77.3 Million
Q3 2024

Nov 13, 2024
SELL
$75.41 - $84.21 $4.15 Million - $4.63 Million
-55,006 Reduced 5.29%
984,781 $78.2 Million
Q2 2024

Aug 13, 2024
BUY
$68.26 - $76.19 $1.42 Million - $1.58 Million
20,776 Added 2.04%
1,039,787 $79.2 Million
Q1 2024

May 10, 2024
SELL
$67.36 - $77.59 $1.3 Million - $1.49 Million
-19,247 Reduced 1.85%
1,019,011 $74.7 Million
Q4 2023

Feb 14, 2024
SELL
$64.27 - $69.9 $635,887 - $691,590
-9,894 Reduced 0.94%
1,038,258 $72.2 Million
Q3 2023

Nov 14, 2023
BUY
$61.9 - $72.77 $1.26 Million - $1.48 Million
20,341 Added 1.98%
1,048,152 $70.1 Million
Q2 2023

Aug 14, 2023
SELL
$53.34 - $63.11 $1.42 Million - $1.68 Million
-26,686 Reduced 2.53%
1,027,811 $64.9 Million
Q1 2023

May 15, 2023
SELL
$51.63 - $56.93 $2.05 Million - $2.26 Million
-39,632 Reduced 3.62%
1,054,497 $60 Million
Q4 2022

Feb 10, 2023
BUY
$51.15 - $57.45 $1.1 Million - $1.23 Million
21,422 Added 2.0%
1,094,129 $56.6 Million
Q3 2022

Nov 14, 2022
SELL
$49.9 - $57.32 $688,769 - $791,187
-13,803 Reduced 1.27%
1,072,707 $56.1 Million
Q2 2022

Aug 12, 2022
SELL
$49.62 - $58.13 $2.16 Million - $2.53 Million
-43,508 Reduced 3.85%
1,086,510 $60.2 Million
Q1 2022

May 13, 2022
SELL
$48.27 - $65.25 $1.13 Million - $1.53 Million
-23,485 Reduced 2.04%
1,130,018 $63 Million
Q4 2021

Feb 14, 2022
BUY
$59.5 - $67.25 $301,962 - $341,293
5,075 Added 0.44%
1,153,503 $75.5 Million
Q3 2021

Nov 12, 2021
BUY
$60.19 - $75.29 $1.6 Million - $2 Million
26,603 Added 2.37%
1,148,428 $74.8 Million
Q2 2021

Aug 13, 2021
BUY
$62.12 - $74.2 $69.7 Million - $83.2 Million
1,121,825 New
1,121,825 $82.5 Million

Others Institutions Holding RDY

# of Institutions
262
Shares Held
92.5M
Call Options Held
0
Put Options Held
0
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.31B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email